D228

N/A

Report date: 2024/09/20 14:48:10
NME

Base Information

Drug NameD228
Drug Alias NameD228D-228
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α modulators
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity of Chinese Academy of SciencesFudan UniversityNanjing University Of Chinese Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNanjing University Of Chinese Medicine
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A